| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Tarr Mark J | President & CEO, Director | 9001 LIBERTY PARKWAY, BIRMINGHAM | /s/ Patrick Darby, attorney-in-fact for Mark J. Tarr | 03 Mar 2026 | 0001304057 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EHC | Encompass Health Common Stock | Tax liability | $235,934 | -2,187 | -0.49% | $107.88 | 440,962 | 28 Feb 2026 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EHC | Non-qualified Stock Option (Right to Buy) | Award | $3,831,916 | +35,461 | $108.06 | 35,461 | 02 Mar 2026 | Encompass Health Common Stock | 35,461 | $108.06 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. |
| F2 | The option becomes exercisable in equal annual installments over a three-year period commencing March 2, 2027. |